Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by L JEFFREY MEDEIROS and ELLEN J SCHLETTE.
L JEFFREY MEDEIROS
Connection Strength
2.273
ELLEN J SCHLETTE
  1. Expression of bcl-3 in chronic lymphocytic leukemia correlates with trisomy 12 and abnormalities of chromosome 19. Am J Clin Pathol. 2005 Mar; 123(3):465-71.
    View in: PubMed
    Score: 0.253
  2. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol. 2003 Nov; 120(5):760-6.
    View in: PubMed
    Score: 0.231
  3. Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol. 2001 Nov; 14(11):1133-40.
    View in: PubMed
    Score: 0.201
  4. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001 Apr; 115(4):571-81.
    View in: PubMed
    Score: 0.193
  5. Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21). Leukemia. 2011 May; 25(5):856-67.
    View in: PubMed
    Score: 0.096
  6. The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Leukemia. 2009 Dec; 23(12):2290-9.
    View in: PubMed
    Score: 0.087
  7. Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am J Clin Pathol. 2008 May; 129(5):714-22.
    View in: PubMed
    Score: 0.079
  8. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer. 2006 Oct 15; 107(8):1844-51.
    View in: PubMed
    Score: 0.071
  9. Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas. Hum Pathol. 2006 Nov; 37(11):1407-13.
    View in: PubMed
    Score: 0.070
  10. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol. 2004 May 01; 22(9):1682-8.
    View in: PubMed
    Score: 0.060
  11. CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype. Arch Pathol Lab Med. 2003 May; 127(5):561-6.
    View in: PubMed
    Score: 0.056
  12. Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up. Arch Pathol Lab Med. 2003 Apr; 127(4):488-91.
    View in: PubMed
    Score: 0.055
  13. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma?variant. Virchows Arch. 2023 Jun; 482(6):1011-1019.
    View in: PubMed
    Score: 0.055
  14. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med. 2003 Mar; 127(3):305-9.
    View in: PubMed
    Score: 0.055
  15. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma. Pathology. 2023 Jun; 55(4):514-524.
    View in: PubMed
    Score: 0.055
  16. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol. 2002 Dec; 15(12):1266-72.
    View in: PubMed
    Score: 0.054
  17. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors. Cytometry B Clin Cytom. 2022 11; 102(6):440-447.
    View in: PubMed
    Score: 0.054
  18. Leukemic mantle cell lymphoma with cells resembling prolymphocytes. Am J Clin Pathol. 2002 Aug; 118(2):305-6; author reply 306.
    View in: PubMed
    Score: 0.053
  19. Pleural posttransplantation lymphoproliferative disorder following liver transplantation. Arch Pathol Lab Med. 2001 Mar; 125(3):419-23.
    View in: PubMed
    Score: 0.048
  20. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP?treated diffuse large B-cell lymphoma. Eur J Haematol. 2020 Apr; 104(4):336-343.
    View in: PubMed
    Score: 0.044
  21. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol. 2020 03; 33(3):367-379.
    View in: PubMed
    Score: 0.043
  22. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption. Hum Pathol. 2018 12; 82:215-231.
    View in: PubMed
    Score: 0.040
  23. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol. 2018 02; 31(2):327-336.
    View in: PubMed
    Score: 0.038
  24. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. J Natl Compr Canc Netw. 2016 08; 14(8):939-44.
    View in: PubMed
    Score: 0.035
  25. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. Hum Pathol. 2014 Mar; 45(3):565-72.
    View in: PubMed
    Score: 0.029
  26. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma. Am J Clin Pathol. 2001 Nov; 116(5):781-2.
    View in: PubMed
    Score: 0.025
  27. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas. Hum Pathol. 2011 Aug; 42(8):1117-24.
    View in: PubMed
    Score: 0.024
  28. mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. Mol Cancer. 2010 Nov 10; 9:292.
    View in: PubMed
    Score: 0.023
  29. Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression. Mod Pathol. 2010 Nov; 23(11):1518-23.
    View in: PubMed
    Score: 0.023
  30. MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol. 2008 Jul; 142(1):36-44.
    View in: PubMed
    Score: 0.020
  31. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer. 2008 Feb 01; 112(3):552-61.
    View in: PubMed
    Score: 0.019
  32. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am J Surg Pathol. 2007 Mar; 31(3):447-53.
    View in: PubMed
    Score: 0.018
  33. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol. 2007 Jan; 136(2):220-8.
    View in: PubMed
    Score: 0.018
  34. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma. Cancer. 2006 Sep 01; 107(5):1084-92.
    View in: PubMed
    Score: 0.018
  35. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia. 2006 Feb; 20(2):280-5.
    View in: PubMed
    Score: 0.017
  36. Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. Am J Clin Pathol. 2001 Dec; 116(6):886-92.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.